Treatment of chronic total occlusion (CTO) Leandro Lasave, MDFifth Series 2011 - SOLACI 2011, Santiago de Chile, Chile26 / 10 / 2015Treatment of chronic total occlusion (CTO) Leandro Lasave, MD
EuroPCR 2024 | 2 Year Outcomes of the New Sirolimus Eluting Bioadaptor vs Resolute Onyx Zotarolimus Elulting Stent
EuroPCR 2024 | NOTION-2: TAVI vs SAVR, Randomized Study on Low-Risk Young Patients with Severe Tricuspid Disease or Bicuspid Stenosis